$MLAB
MESA LABORATORIES INC /CO/

2022 Q3 Form 10-Q Financial Statement

#000143774922018744 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $58.75M $50.45M $58.88M
YoY Change 63.92% 44.48% 55.09%
Cost Of Revenue $22.36M $19.11M $23.77M
YoY Change 76.09% 50.38% 79.64%
Gross Profit $36.39M $31.34M $35.11M
YoY Change 57.24% 41.11% 41.95%
Gross Profit Margin 61.93% 62.12% 59.63%
Selling, General & Admin $27.40M $30.24M $30.04M
YoY Change 67.84% 85.75% 69.93%
% of Gross Profit 75.31% 96.47% 85.56%
Research & Development $4.989M $5.700M $5.179M
YoY Change 90.93% 102.77% 93.97%
% of Gross Profit 13.71% 18.19% 14.75%
Depreciation & Amortization $8.055M $8.134M $24.61M
YoY Change 88.33% 77.91% 120.13%
% of Gross Profit 22.14% 25.95% 70.08%
Operating Expenses $32.39M $35.94M $35.22M
YoY Change 71.03% 88.26% 73.08%
Operating Profit $3.995M -$4.594M -$110.0K
YoY Change -4.9% -247.1% -102.51%
Interest Expense $1.214M $1.014M -$1.238M
YoY Change 48.96% 16.02% -41.33%
% of Operating Profit 30.39%
Other Income/Expense, Net -$611.0K -$818.0K $1.302M
YoY Change -278.65% -52.02% -51.96%
Pretax Income $3.384M -$5.412M -$46.00K
YoY Change -25.51% -481.66% -100.94%
Income Tax $2.078M -$3.974M $1.738M
% Of Pretax Income 61.41%
Net Earnings $1.306M -$1.438M -$1.784M
YoY Change -64.89% -172.08% -145.51%
Net Earnings / Revenue 2.22% -2.85% -3.03%
Basic Earnings Per Share $0.25 -$0.27
Diluted Earnings Per Share $0.24 -$0.27 -$339.7K
COMMON SHARES
Basic Shares Outstanding 5.317M 5.273M 5.246M
Diluted Shares Outstanding 5.364M 5.273M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.38M $43.75M $49.35M
YoY Change -88.37% -84.13% -81.3%
Cash & Equivalents $32.38M $43.75M $49.35M
Short-Term Investments
Other Short-Term Assets $3.541M $5.312M $3.735M
YoY Change -44.3% -23.03% -23.78%
Inventory $28.04M $26.87M $24.61M
Prepaid Expenses
Receivables $41.81M $41.84M $41.22M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $116.3M $128.1M $124.3M
YoY Change -63.6% -59.36% -59.07%
LONG-TERM ASSETS
Property, Plant & Equipment $28.22M $28.01M $28.62M
YoY Change 26.04% 27.58% 30.1%
Goodwill $278.0M $283.6M $291.2M
YoY Change 73.78% 74.26% 81.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.83M $10.42M $11.83M
YoY Change 446.99% 373.82% 367.59%
Total Long-Term Assets $540.0M $557.7M $583.1M
YoY Change 86.39% 87.66% 95.83%
TOTAL ASSETS
Total Short-Term Assets $116.3M $128.1M $124.3M
Total Long-Term Assets $540.0M $557.7M $583.1M
Total Assets $656.2M $685.8M $707.4M
YoY Change 7.74% 11.97% 17.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.738M $7.557M $7.897M
YoY Change 73.38% 86.82% 76.55%
Accrued Expenses $12.46M $11.90M $11.61M
YoY Change 40.97% 19.95% 16.75%
Deferred Revenue $13.83M $15.27M $13.83M
YoY Change 41.99% 70.76% 57.57%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.51M $44.13M $48.06M
YoY Change 44.67% 31.93% 47.48%
LONG-TERM LIABILITIES
Long-Term Debt $196.8M $216.6M $218.4M
YoY Change 16.52% 28.39% 49.87%
Other Long-Term Liabilities $6.826M $7.340M $7.924M
YoY Change 1465.6% 1284.91% 1008.25%
Total Long-Term Liabilities $6.826M $7.340M $7.924M
YoY Change 1465.6% 1284.91% 1008.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.51M $44.13M $48.06M
Total Long-Term Liabilities $6.826M $7.340M $7.924M
Total Liabilities $282.0M $305.4M $313.6M
YoY Change 34.49% 43.04% 60.6%
SHAREHOLDERS EQUITY
Retained Earnings $74.85M $74.39M $76.68M
YoY Change -8.94% -6.2% 5.82%
Common Stock $324.9M $318.3M $313.5M
YoY Change 7.5% 6.75% -1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $374.2M $380.4M $393.8M
YoY Change
Total Liabilities & Shareholders Equity $656.2M $685.8M $707.4M
YoY Change 7.74% 11.97% 17.61%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $1.306M -$1.438M -$1.784M
YoY Change -64.89% -172.08% -145.51%
Depreciation, Depletion And Amortization $8.055M $8.134M $24.61M
YoY Change 88.33% 77.91% 120.13%
Cash From Operating Activities $10.56M -$2.811M $9.302M
YoY Change 138.09% -129.31% -31.2%
INVESTING ACTIVITIES
Capital Expenditures -$1.639M $225.0K -$782.0K
YoY Change 74.73% -65.54% -24.81%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.639M -$225.0K -$782.0K
YoY Change 74.73% -65.54% -24.81%
FINANCING ACTIVITIES
Cash Dividend Paid $843.0K
YoY Change 2.31%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.65M -$1.407M -10.05M
YoY Change -1710.19% -630.94% 856.86%
NET CHANGE
Cash From Operating Activities 10.56M -$2.811M 9.302M
Cash From Investing Activities -1.639M -$225.0K -782.0K
Cash From Financing Activities -18.65M -$1.407M -10.05M
Net Change In Cash -9.728M -$5.599M -1.527M
YoY Change -309.02% -147.27% -113.36%
FREE CASH FLOW
Cash From Operating Activities $10.56M -$2.811M $9.302M
Capital Expenditures -$1.639M $225.0K -$782.0K
Free Cash Flow $12.20M -$3.036M $10.08M
YoY Change 127.03% -133.97% -30.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1035000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
630000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18495000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17726000 usd
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5297308
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5297308
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5265627
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5265627
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
380431000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
399003000 usd
CY2022Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-7601000 usd
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.64
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14717000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15268000 usd
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
0-11740
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13830000 usd
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-0872291
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
12100 West Sixth Avenue
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43747000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49346000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41840000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11901000 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11611000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44127000 usd
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80228
CY2022Q2 dei City Area Code
CityAreaCode
303
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
987-8000
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2022Q2 dei Trading Symbol
TradingSymbol
MLAB
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
48055000 usd
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
37323000 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
39224000 usd
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Goodwill
Goodwill
283565000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
291166000 usd
CY2022Q2 us-gaap Assets
Assets
685811000 usd
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5317270
CY2022Q1 us-gaap Assets
Assets
707369000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7557000 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7897000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9401000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
12709000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
31341000 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41224000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
26874000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
24606000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15666000 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9142000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
128127000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
124318000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28006000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28620000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
689000 usd
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1318000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10424000 usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11830000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
235000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250117000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7340000 usd
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7924000 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
47000000 usd
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
49000000 usd
CY2022Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
169590000 usd
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
169365000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
305380000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
313568000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
318328000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
313460000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74394000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
76675000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12291000 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3666000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
380431000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
393801000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
685811000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
707369000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
19112000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5273000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5301000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
22211000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1995000 usd
CY2022Q2 us-gaap Selling Expense
SellingExpense
10023000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5273000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5152000
CY2021Q2 us-gaap Selling Expense
SellingExpense
4858000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20212000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11419000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5700000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2811000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
35935000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
19088000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4594000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3123000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1014000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
874000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
196000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-831000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-818000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1705000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5412000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1418000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3974000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-577000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1438000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1995000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15957000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5371000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17395000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7366000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1995000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8134000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4572000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3432000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2197000 usd
CY2022Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
225000 usd
CY2021Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
221000 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-908000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1763000 usd
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
826000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1484000 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3285000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2732000 usd
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
753000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2180000 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1631000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15957000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-205000 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-476000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
843000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3432000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5328000 usd
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
867000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1436000 usd
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
138000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2811000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9589000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
225000 usd
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
653000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-225000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-653000 usd
CY2022Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
2000000 usd
CY2021Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 usd
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
843000 usd
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
824000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1436000 usd
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1089000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1407000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
265000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1156000 usd
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2644000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5599000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11845000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49346000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263865000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43747000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
275710000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
393801000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1436000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1438000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
406227000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1089000 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
824000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2197000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5371000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1995000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34920000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
291166000 usd
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4419000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
283565000 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9710000 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6015000 usd
CY2022Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Prior Period Reclassification</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certain amounts presented in Note <em style="font: inherit;">3.</em> "Revenue Recognition" in prior periods of fiscal year <em style="font: inherit;">2022</em> have been reclassified out of revenues from consumables and into revenues from hardware and services. These reclassifications have <em style="font: inherit;">not</em> resulted in any change to the Condensed Consolidated Financial Statements for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2022 </em>and <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2022Q2 us-gaap Inventory Net
InventoryNet
26874000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50453000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34920000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50453000 usd
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
14172000 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2150000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15069000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3298000 usd
CY2022Q2 mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
3497000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15268000 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
15014000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
24606000 usd
CY2022Q2 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
4173000 usd
CY2022Q1 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
2871000 usd
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
6181000 usd
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
2536000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5312000 usd
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
3735000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15666000 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9142000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
335400000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
85283000 usd
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3116000 usd
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3677000 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2551000 usd
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2069000 usd
CY2022Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1596000 usd
CY2022Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1503000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9401000 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14717000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
325224000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
90224000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
235000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250117000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7320000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3816000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
21591000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
28278000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26704000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25950000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
25453000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3432000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2197000 usd
CY2022Q2 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1992000 usd
CY2021Q2 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-2785000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1440000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
-588000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
202000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
167.14
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18261000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
42000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
185570
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
231150
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
93120
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
224000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
174.93
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9493000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1995000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5273000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5152000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5273000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5301000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
968000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
654000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.734 pure
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.407 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q2 us-gaap Gross Profit
GrossProfit
31341000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
22211000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5412000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1418000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
26874000 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
24606000 usd

Files In Submission

Name View Source Status
0001437749-22-018744-index-headers.html Edgar Link pending
0001437749-22-018744-index.html Edgar Link pending
0001437749-22-018744.txt Edgar Link pending
0001437749-22-018744-xbrl.zip Edgar Link pending
ex_385229.htm Edgar Link pending
ex_385230.htm Edgar Link pending
ex_385231.htm Edgar Link pending
ex_385232.htm Edgar Link pending
ex_398914.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20220630.xsd Edgar Link pending
mlab-20220630_cal.xml Edgar Link unprocessable
mlab-20220630_def.xml Edgar Link unprocessable
mlab-20220630_lab.xml Edgar Link unprocessable
mlab-20220630_pre.xml Edgar Link unprocessable
mlab20220630_10q.htm Edgar Link pending
mlab20220630_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending